Anti-NMDA receptor encephalitis classification

Jump to navigation Jump to search

Anti-NMDA receptor encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anti-NMDA receptor encephalitis from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anti-NMDA receptor encephalitis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anti-NMDA receptor encephalitis classification

CDC on Anti-NMDA receptor encephalitis classification

Anti-NMDA receptor encephalitis classification in the news

Blogs on Anti-NMDA receptor encephalitis classification

Directions to Hospitals Treating Anti-NMDA receptor encephalitis

Risk calculators and risk factors for Anti-NMDA receptor encephalitis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; AE Dheeraj Makkar, M.D.[2]

Overview

Classification

Anti NMDA Encephalitis may be classified into three subtypes, depending on the timing of presentation and duration.


Subtype Symptoms Duration
Class 1 Primarily by a catatonic or stuporous state Less than 60 days
Class 2 Primarily psychotic state More than 60 days
Class 3 Primarily catatonic or stuporous More than 60 days

References

Template:WH Template:WS